Profil ads

How can mode of action studies contribute to understanding drug effects and support product labeling? In our free on-demand webinar, “Mode of Action Studies and Label Texts in the Metabolic Field,” Dr. Hans de Vries explores the role of clinical pharmacology studies in metabolic drug development, using examples from research conducted at Profil. Gain insights into relevant methodologies, clinical trial endpoints, and key considerations for designing mode of action studies.

Profil's scientific contributions at EASD 2026 🎤 Research conducted at Profil will be featured in three presentations at this year’s EASD, in collaboration with Gan & Lee and Sun Pharma. If you are attending EASD, consider adding these sessions to your schedule: 📅 Tuesday, 29 September | 10:00–11:30 | OP2 In collaboration with Gan & Lee Presented by Dr. Hans de Vries Pharmacodynamic properties of novel once-daily insulin GZR33 in people with type 1 diabetes 📅 Wednesday, 30 September | 11:45–12:45 | SO 075 In collaboration with Sun Pharma Presented by Dr. Rajamannar Thennati Utreglutide (GL0034) shows comparable tolerability and efficacy with different dose escalation regimens in overweight and obese adults with type 2 diabetes 📅 Thursday, 1 October | 12:45–13:45 | LBA SO 09 In collaboration with Gan & Lee Presented by Dr. Hans de Vries Pharmacokinetic and pharmacodynamic properties of novel once-weekly insulin GZR4 versus insulin degludec in people with type 2 diabetes We look forward to the scientific exchange at EASD and to discussing how clinical research continues to advance new treatment approaches in diabetes. You can also meet the Profil team throughout the congress at Booth F.04. #EASD2026 #DiabetesResearch #ClinicalResearch #ClinicalPharmacology #Diabetes #Profil

Which findings from a mode of action study can ultimately contribute to a product label? In our upcoming webinar, Dr. Hans de Vries, Lead Scientist at Profil, explores how well-designed mode of action studies can generate meaningful insights for metabolic drug development based on a tirzepatide study conducted at Profil as a real-world example. Join us to discover which methodologies, endpoints and study outcomes matter.

Heading to BIO International? Profil will be there to meet innovators in diabetes, obesity, and metabolic drug development. Connect with our experts to discuss your early-phase clinical research needs. Schedule a meeting with us via the BIO Partnering tool or email ([email protected]).

Looking for a specialized CRO partner in diabetes or obesity research? Meet Profil at BIO International and discover how our scientific expertise, dedicated clinical research infrastructure, and metabolic trial experience can support your next development milestone.

Heading to BIO International? Profil will be there to meet innovators in diabetes, obesity, and metabolic drug development. Connect with our experts to discuss your early-phase clinical research needs. Schedule a meeting with us via the BIO Partnering tool or email ([email protected]).